Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 8.6 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 1, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 72,086 shares of its common stock on Oct 1, with a total market value of approximately $8.6 million.
BioNTech's InstaDeep Unit Showcases AI Breakthroughs in Vaccines and Cancer Treatments
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 9 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 30, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 76,114 shares of its common stock on Sep 30, with a total market value of approximately $9 million.
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales
Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 4.38 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 27, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 37,204 shares of its common stock on Sep 27, with a total market value of approximately $4.38 million.
Deep Sea : Hope that next week it will rise.
Stock_Drift OP Deep Sea : More than it is right meow!! ?